136 related articles for article (PubMed ID: 11464449)
1. Synthetic statins: more data on newer lipid-lowering agents.
Wierzbicki AS
Curr Med Res Opin; 2001; 17(1):74-7. PubMed ID: 11464449
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
Sharma R; Mahajan M; Singh B; Bal BS; Kant R
J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic effects of statins in atherosclerosis and diabetes.
Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
[TBL] [Abstract][Full Text] [Related]
4. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
5. Fluvastatin as co-medication in heart transplant recipients with elevated creatine-kinase.
Sadoni S; Kaczmarek I; Delgado O; Schmöckel M; Reichart B; Meiser B
Transplant Proc; 2007 Mar; 39(2):558-9. PubMed ID: 17362781
[TBL] [Abstract][Full Text] [Related]
6. Intensive lipid-lowering therapy for patients with aortic stenosis.
Pedersen TR
Am J Cardiol; 2008 Dec; 102(11):1571-6. PubMed ID: 19026317
[TBL] [Abstract][Full Text] [Related]
7. A clinical focus on statins.
Auer J; Eber B
Curr Opin Investig Drugs; 2001 Mar; 2(3):382-8. PubMed ID: 11575709
[TBL] [Abstract][Full Text] [Related]
8. Differences between statins on clinical endpoints: a population-based cohort study.
Dieleman JP; van Wyk JT; van Wijk MA; van Herpen G; Straus SM; Dunselman H; Sturkenboom MC
Curr Med Res Opin; 2005 Sep; 21(9):1461-8. PubMed ID: 16197665
[TBL] [Abstract][Full Text] [Related]
9. Statins and osteoporosis: new role for old drugs.
Jadhav SB; Jain GK
J Pharm Pharmacol; 2006 Jan; 58(1):3-18. PubMed ID: 16393459
[TBL] [Abstract][Full Text] [Related]
10. Toward a role for statins in immunomodulation.
Mach F
Mol Interv; 2002 Dec; 2(8):478-80. PubMed ID: 14993398
[TBL] [Abstract][Full Text] [Related]
11. Use of an indirect effect model to describe the LDL cholesterol-lowering effect by statins in hypercholesterolaemic patients.
Faltaos DW; Urien S; Carreau V; Chauvenet M; Hulot JS; Giral P; Bruckert E; Lechat P
Fundam Clin Pharmacol; 2006 Jun; 20(3):321-30. PubMed ID: 16671968
[TBL] [Abstract][Full Text] [Related]
12. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
Zhou Z; Rahme E; Pilote L
Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888
[TBL] [Abstract][Full Text] [Related]
13. Statins: much more than just a lipid-lowering therapy.
Raja SG; Dreyfus GD
Indian Heart J; 2004; 56(3):204-9. PubMed ID: 15584561
[No Abstract] [Full Text] [Related]
14. [Substantiation of increasing doses of statins in clinical practice].
Susekov AV
Ter Arkh; 2001; 73(4):76-80. PubMed ID: 11494456
[No Abstract] [Full Text] [Related]
15. Update on statins.
Mason P
J Vasc Nurs; 2004 Jun; 22(2):49-50. PubMed ID: 15179417
[No Abstract] [Full Text] [Related]
16. The use over time of statins in coronary patients in an Italian tertiary referral center.
Gaspardone A; Proietti I; Altamura L; Tomai F; Versaci F; Crea F; Chiariello L; Gioffrè PA
Ital Heart J; 2001 Nov; 2(11):848-53. PubMed ID: 11770871
[TBL] [Abstract][Full Text] [Related]
17. Comparative neuroprotective profile of statins in quinolinic acid induced neurotoxicity in rats.
Kalonia H; Kumar P; Kumar A
Behav Brain Res; 2011 Jan; 216(1):220-8. PubMed ID: 20696189
[TBL] [Abstract][Full Text] [Related]
18. HMG-CoA reductase inhibition improves anti-aging klotho protein expression and arteriosclerosis in rats with chronic inhibition of nitric oxide synthesis.
Kuwahara N; Sasaki S; Kobara M; Nakata T; Tatsumi T; Irie H; Narumiya H; Hatta T; Takeda K; Matsubara H; Hushiki S
Int J Cardiol; 2008 Jan; 123(2):84-90. PubMed ID: 17434618
[TBL] [Abstract][Full Text] [Related]
19. Different anti-HCV profiles of statins and their potential for combination therapy with interferon.
Ikeda M; Abe K; Yamada M; Dansako H; Naka K; Kato N
Hepatology; 2006 Jul; 44(1):117-25. PubMed ID: 16799963
[TBL] [Abstract][Full Text] [Related]
20. Binding thermodynamics of statins to HMG-CoA reductase.
Carbonell T; Freire E
Biochemistry; 2005 Sep; 44(35):11741-8. PubMed ID: 16128575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
